MARYLYNN GONSALVES: Open Payments
NPI 1871539064 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 14 payments from 9 companies in 2025. Trend: 2023 $403 · 2024 $167 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $70 |
| ABBVIE INC. | 2 | $39 |
| PFIZER INC. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| AERIN MEDICAL INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Abbott Laboratories | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: QULIPTA, PREVNAR 20, Wegovy, JARDIANCE, Saxenda, GARDASIL 9, VIVAER STYLUS, FARXIGA.
Industry payments across MD — which companies pay providers there.
